Abstract:IMPORTANCE It remains unknown whether neurodevelopmental impairments are directly associated with the structural development of the brain in offspring with fetal growth restriction (FGR) and mothers with preeclampsia (PE) or gestational hypertension (GH). OBJECTIVES To assess whether fetal corpus callosum (CC) development differed among pregnancies with PE or GH with FGR, pregnancies with PE or GH without FGR, and normotensive pregnancies, particularly the severity of maternal disease and FGR, and to identify the association between adverse perinatal outcomes and structural development of the CC in fetuses with FGR in pregnancies with PE or GH. DESIGN, SETTING, AND PARTICIPANTS This retrospective matched case-control study was conducted between January 1, 2014, and January 31, 2021, at Women's Hospital, Zhejiang University School of Medicine in Hangzhou, China. The participant group included cases of singleton pregnancies with PE or GH with FGR; the control groups included cases with PG or GH without FGR and cases with paired normotensive pregnancy. EXPOSURES Maternal PE or GH and FGR. MAIN OUTCOMES AND MEASURES The length, thickness, total area, subdivision areas, and apparent diffusion coefficient (ADC) values of fetal CC were measured on magnetic resonance imaging (MRI) and analyzed. The association between adverse perinatal outcomes and structural development of CC was further investigated. RESULTS A total of 56 pregnant individuals with singleton pregnancies and PE or GH and fetuses with FGR were enrolled (maternal median [IQR] age, 29.0 [26.0-34.0] years; mean [SD] gestational age at MRI, 33.6 [2.5] weeks). Significant patterns of decreased median (IQR)fetal CC length (0.4284 [0.4079-0.4470] mm vs 0.4614 [0.4461-0.4944] mm, P < .001, vs 0.4591[0.4310-0.4927] mm, P < .001) and mean (SD) CC total area (1.0779 [0.1931] mm(2) vs 1.1896 [0.1803] mm(2), P = .001, vs 1.1438 [0.1935] mm(2), P = .02), adjusted for the cephalic index, was observed in cases of PE or GH with FGR compared with cases without FGR and cases with normotensive pregnancy. The splenium region of fetal CC also exhibited the distinct alterations in macrostructural development (with FGR: 0.3149 [0.0697] mm(2) vs without FGR: 0.3727 [0.0698] mm(2), P < .001, vs normotensive pregnancies: 0.3565 [0.0763] mm(2), P < .001) and microstructural development (median [IQR] ADC values: 1.47 [1.38-1.57] x 10(-3) mm(2)/s vs 1.57 [1.53-1.63] x 10(-3) mm(2)/s. P = .009. vs 1.63 [1.501.70] x 10(-3) mm(2)/s. P < .001) in all groups. Furthermore, significant associations were found between structural abnormality of the splenium region and adverse perinatal outcomes in the PE or GH with FGR group (mean [SD] ADC value:1.40 [0.07] x 10(-3) mm(2)/s; P = .04). CONCLUSIONS AND RELEVANCE Results of this study suggest that, in fetuses with FGR in pregnancies with PE or GH, decreased structural development of the CC, predominantly the splenium region, may be significantly associated with a higher risk of adverse perinatal outcomes and may be regarded as an MRI-based biomarker for better prenatal counseling and early management decisions.

Fetal Familial Cerebral Cavernous Malformation With a Novel Heterozygous KRIT1 Variation

Novel KRIT1/CCM1 and MGC4607/CCM2 Gene Variants in Chinese Families with Cerebral Cavernous Malformations

Identification of a Novel CCM1 Frameshift Mutation in a Chinese Han Family With Multiple Cerebral Cavernous Malformations

A novel KRIT1/CCM1 mutation accompanied by a NOTCH3 mutation in a Chinese family with multiple cerebral cavernous malformations

A Chinese Family With Cerebral Cavernous Malformation Caused by a Frameshift Mutation of the CCM1 Gene: A Case Report and Review of the Literature

A Novel CCM2 Missense Variant Caused Cerebral Cavernous Malformations in a Chinese Family

[Identification of a Novel Inheritable CCM1 Gene Mutation of 671del AT in a Chinese Family with Cerebral Cavernous Malformation].

A novel CCM3 mutation associated with cerebral cavernous malformation in a Chinese family

Clinical, Pathological, Magnetic Resonance Imaging Features of a Chinese Family with Cerebral Cavernous Malformation Induced by a Novel CCM1 Gene Mutation (P07.232)

Case Report: Prenatal Diagnosis of Fetal Intracranial Hemorrhage Due to Compound Mutations in the JAM3 Gene

Features of a Chinese Family with Cerebral Cavernous Malformation Induced by a Novel CCM1 Gene Mutation

Molecular genetic features and clinical manifestations in Chinese familial cerebral cavernous malformation: from a novel KRIT1/CCM1 mutation (c.1119dupT) to an overall view

Cerebroretinal Microangiopathy with Calcifications and Cysts

Loss of heterozygosity in CCM2 cDNA revealing a structural variant causing multiple cerebral cavernous malformations

A Novel Deletion Mutation in CCM1 Gene (krit1) is Detected in a Chinese Family with Cerebral Cavernous Malformations

Comprehensive analysis of Novel mutations in CCM1/KRIT1 and CCM2/MGC4607 and their clinical implications in Cerebral Cavernous malformations

Association of Corpus Callosum Development with Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension.

Case report：A new foetal sonographic characteristic of Baraitser–Winter cerebrofrontofacial syndrome with ACTB mutation

Identification of a Likely Pathogenic Structural Variation in the LAMA1 Gene by Bionano Optical Mapping.

A genetic variant in the MAST1 gene is associated with mega‐corpus‐callosum syndrome with hypoplastic cerebellar vermis, in a fetus

Novel, mutable site in the cerebral cavernous malformation-1 gene in Chinese sporadic intracranial cavernous malformation patients